EcoDrugPlus

Solute Carrier Family 9 Member A3

Ensembl ID : ENSHBUG00000017081
Gene Symbol: SLC9A3
3 Cross references
223 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSHBUG00000016991
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSHBUG00000002593
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSHBUG00000017267
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSHBUG00000006466
Gene Symbol: LOC102300655
2 Cross references
178 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSHBUG00000005127
Gene Symbol: LOC102292341
2 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSHBUG00000006268
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSHBUG00000014322
Gene Symbol: LOC102302086
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSHBUG00000021795
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSHBUG00000021143
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSHBUG00000001397
Gene Symbol: TACR1
3 Cross references
195 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSHBUG00000017895
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).